$UTI

Coliseum Capital Management, LLC sold $124.2M of UTI (indirect holdings)

Coliseum Capital Management, LLC sold 3,000,000 indirectly-held shares of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) at $41.40 ($124.20M total) on 2026-06-08.

Original reporting
SEC EDGAR · Coliseum Capital Management, LLC
Published Jun 10, 2026, 9:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 10, 2026, 10:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$UTI
Neutral
medium confidence
Mentioned
$UTI
Relevance
8/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UTINeutralLow
01

Why it matters

A director-related open-market sale of 3,000,000 shares (~$124.2M) can influence short-term sentiment and order-flow expectations, but it does not, by itself, change fundamentals.

02

Market read

Traders may watch for follow-on selling/positioning effects, but the filing alone is unlikely to drive a sustained repricing without additional company catalysts.

03

What to watch

No 10b5-1 plan is disclosed here, so traders may overinterpret intent; also, the filing does not quantify whether other insiders or institutions are buying/selling concurrently.

Relevance 8/10Novelty 8/10Timing: Filed 2026-06-10; sale dated 2026-06-08

Background

The article is an SEC Form 4 insider transaction disclosure for Universal Technical Institute Inc (UTI).

Company-level read

Ticker impact

$UTINeutralMedium confidence
Context

Coliseum Capital Management, LLC reported an open-market sale of 3,000,000 UTI shares for about $124.2M via an SEC Form 4.

Expected impact

Likely limited near-term impact; any effect is more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan stated, but the article provides no accompanying company-specific negative catalyst (earnings, guidance, litigation, or regulatory action).

Market effects

No sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale may be liquidity/portfolio rebalancing rather than a bearish signal, especially since the article lacks any negative operational or regulatory trigger.

Key entities

  • UNIVERSAL TECHNICAL INSTITUTE INC

    UTI, the company whose shares were sold in the reported insider transaction.

  • Coliseum Capital Management, LLC

    Reported the open-market sale of 3,000,000 UTI shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UTIMed

UTI Expands Credit Facility to $200 Million in New Five

Universal Technical Institute (UTI) secured a new $200M revolving credit facility, up from $125M, with a five-year term. The facility, led by Fifth Third Bank, includes a $75M letter of credit sublimit and a $75M incremental facility option. UTI plans to use the funds for working capital, internal initiatives, and potential acquisitions. The expanded lending syndicate suggests increased institutional confidence in UTI's growth strategy.

$UTIMed

Universal Technical Institute Secures $200 Million Revolving Credit Facility, Maturing 2031

Universal Technical Institute (UTI) secured a $200 million revolving credit facility maturing in 2031, refinancing its prior agreement and bolstering liquidity. The facility, arranged by Fifth Third Bank, includes a $15 million swingline, a $75 million letter-of-credit sublimit, and up to $75 million of uncommitted incremental capacity. Borrowings bear interest at Term SOFR plus 1.50%–2.25% or Base Rate plus 0.50%–1.25%, with an unused fee of 0.20%–0.35%. The company also executed a Guaranty and

$UTIMedAI 8/10

Universal Technical Institute Q3 Earnings Call Highlights

Universal Technical Institute (NYSE:UTI) reported Q3 revenue of $138 million, up 5%, and Concorde revenue of $80.9 million, up 11.1%. Management cited employer shortages and said high school automotive and diesel starts were below expectations due to admissions execution. FY2026 guidance: revenue $893m-$900m, net income $32m-$36m, EPS $0.57-$0.64, baseline adj. EBITDA >$135m.

$UTIMed

UNIVERSAL TECHNICAL INSTITUTE INC (UTI): Results of Operations and Financial Condition

UNIVERSAL TECHNICAL INSTITUTE INC (UTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Universal Technical Institute Reports Fiscal Year 2026 Third Quarter Results Total New Student Start Growth Exceeded Expectations Driven by Strong Demand and Continued Momentum Across New Campuses, Reinforcing Confidence in Long-Term North Star Targets PHOENIX, ARIZ.

$UTIMedAI 8/10

UTI Asset Management Company Limited Reports Q1 FY27 Results; Consolidated Total Income Up 6.7% YoY to ₹585 Crore; Total Group AUM Crosses ₹20.56 Lakh Crore

UTI Asset Management Company Limited (UTI AMC) reported unaudited Q1 FY27 results for the quarter ended June 30, 2026. Consolidated total income rose 6.7% YoY to ₹585.23 crore, with consolidated PAT attributable to owners up 24.1% YoY to ₹293.86 crore. Group AUM crossed ₹20.56 lakh crore and live folios reached 1.42 crore, with SIP inflows of ₹2,502 crore. Source: Equity Bulls.